Differential effects of progestins: European Progestin Club

Maturitas

Volumn 46, Issue SUPPL. 1, 2003, Pages

  Schindler, Adolf E ^a  

^a Institute for Medical Research and Education Essen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

19 NORPREGNANE; CARBOHYDRATE; ESTROGEN; GESTAGEN; HYDROXYPROGESTERONE; LIPID; MEDROXYPROGESTERONE ACETATE; NANDROLONE; PREGNANE DERIVATIVE; PROGESTERONE; PROGESTERONE DERIVATIVE; RETROPROGESTERONE; SOMATOMEDIN C; SPIRONOLACTONE; UNCLASSIFIED DRUG;

BONE; BREAST CANCER; CARBOHYDRATE METABOLISM; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ENDOMETRIUM; GYNECOLOGY; HOMEOSTASIS; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; LONG TERM CARE; MEDICAL SOCIETY; MENOPAUSAL SYNDROME; NONHUMAN; OBSTETRICS; OVULATION INHIBITION; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 0345599281     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.09.013     Document Type: Editorial

References (44)

1. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W.et al. Progestins: present and future. J. Steroid. Biochem. Mol. Biol. 59:1996;357-363. [editorial].
2. Schindler AE, Ebert C, editors. Gestagene - Gegenwart und Zukunft. Zbl Gynäkol 1997;119(Suppl):1-77.
3. Campagnoli C., Belforte B., Di Sario M.M., Lesca L.L. Lipid profile during hormone replacement therapy: effect of different progestins? Zbl. Gynäkol. 119(Suppl.):1997;1-6.
4. Campagnoli C., Giglia N., Cantamessa C., Di Sario M.M., Lesca L.L. Effect of progestin on IGF-1 serum level in estrogen-treated postmenopausal women. Zbl. Gynäkol. 119(Suppl.):1997;7-11.
5. Wieser E., Gruber D.M., Tschugguel W., Huber J.C. Progesteron und die Stickstoffmonooxydsysteme. Zbl. Gynäkol. 119(Suppl.):1997;12-16.
6. Schindler A.E. Gestagene und Hämostase. Zbl. Gynäkol. 119(Suppl.):1997;17-19.
7. Gruber D.M., Wieser F., Sato M., Huber J.C. Die neurotrope Wirkung des Progesterons. Zbl. Gynäkol. 119(Suppl.):1997;20-24.
8. Druckmann R. Die Rolle der Gestagene in der Pubertät und Adoleszenz. Zbl. Gynäkol. 119(Suppl.):1997;25-33.
9. Gruber D.M., Wieser F., Sato M., Huber J.C. Die Bedeutung des Progesterons und der Gestagene im Klimakterium. Zbl. Gynäkol. 119(Suppl.):1997;34-37.
10. Campagnoli C., Biglia N., Giai M., Sismondi B. Progestins and breast cancer risk. Zbl. Gynäkol. 119(Suppl.):1997;38-42.
11. Thijssen J.H.H. Estrogens, progestins and proliferation. Zbl. Gynäkol. 119(Suppl.):1997;43-47.
12. Pasqualini J.R. Role, control and expression of estrone-sulfatase and 17β-hydroxysteroid-dehydrogenase activities in human breast cancer. Zbl. Gynäkol. 119(Suppl.):1997;48-53.
13. Schweppe K.W. Die Bedeutung der Gestagene zur Behandlung der Mastopathie. Zbl. Gynäkol. 119(Suppl.):1997;54-58.
14. Schindler A.E. Gestagene und Endometrium. Zbl. Gynäkol. 119(Suppl.):1997;59-63.
15. Schweppe K.W. Die Bedeutung der Gestagene zur Behandlung der Endometriose. Zbl. Gynäkol. 119(Suppl.):1997;64-69.
16. Thijssen J.H.H. Progestins and bone. Zbl. Gynäkol. 119(Suppl.):1997;70-74.
17. Schindler A.E. Immunologie und Gestagene bei der Schwangerschaft. Zbl. Gynäkol. 119(Suppl.):1997;75-77.
18. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W.et al. European Progestin Club aspects of progestin activity on the breast. Maturitas. 29:1998;61-65.
19. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W. Aspekte der Gestagenwirkung auf die Brust. Frauenarzt. 39:1998;1423-1427.
20. Schindler AE, editor. Progestins - the neglected stars. Gynec Endocrinol 1999;13(Suppl 4):1-50.
21. Sitruk-Ware R., Plu-Bureau G. Progestins in cancer. Gynec. Endocrinol. 13(Suppl. 4):1999;3-9.
22. Pasqualini J.R., Ebert C. Biological effects in breast cancer. Gynec. Endocrinol. 13(Suppl. 4):1999;11-19.
23. Schweppe K.W. Progestins and uterine leiomyoma. Gynec. Endocrinol. 13(Suppl. 4):1999;21-24.
24. Thijssen J.H.H., Druckmann R. Effects of progestins on bone: an update. Gynec. Endocrinol. 13(Suppl. 4):1999;25-39.
25. Gruber D.M., Sato M.O., Wieser F., Warner C., Huber J.C. Progesterone and neurology. Gynec. Endocrinol. 13(Suppl. 4):1999;41-45.
26. Schindler A.E. Immunology and progestins in pregnancy. Gynec. Endocrinol. 13(Suppl. 4):1999;47-50.
27. Huber J.C., Campagnoli C., Druckmann R., Ebert C., Pasqualini J.R., Ruby J.et al. European Progestin Club recommendation for estrogen and progestin replacement in the climacteric and postmenopause. Maturitas. 33:1999;197-209.
28. Schindler AE, editor. Conjugated estrogens: the natural SERMs? Gynec Endocrinol 1999;13(Suppl 6):1-40.
29. Pasqualini J.R., Ebert C., Chetrite G.S. The SEEM: selective estrogen enzyme modulators in breast cancer. Gynec. Endocrinol. 13(Suppl. 6):1999;1-8.
30. Gruber D.M., Huber J.C. Conjugated estrogens: the natural SERMs? Gynec. Endocrinol. 13(Suppl. 6):1999;9-12.
31. Campagnoli R., Ambroggio S., Biglia N., Sismondi B. Conjugated estrogens and breast cancer risk. Gynec. Endocrinol. 13(Suppl. 6):1999;13-19.
32. Windler E. Modification of serum lipids and cardiovascular risk by estrogenic active compounds. Gynec. Endocrinol. 13(Suppl. 6):1999;21-28.
33. Thijssen J.H.H. Quantitative assessment of bone mineral density during estrogen replacement therapy. Gynec. Endocrinol. 13(Suppl. 6):1999;29-34.
34. Schindler A.E. Role of progestins in the premenopausal climacteric. Gynec. Endocrinol. 13(Suppl. 6):1999;35-40.
35. Schindler AE, editor. The role of progestins in different target tissues. Gynec Endocrinol 2001;15(Suppl 6):7-76.
36. Rosano G.M.C., Mercuro G., Vitale C., Rossini P., Galetta P., Fini M. How progestins influence the cardiovascular effect of hormone replacement therapy. Gynec. Endocrinol. 15(Suppl. 6):2001;9-17.
37. Huber J.C., Gruber D.M. Immunological and dermatological impact of progesterone. Gynec. Endocrinol. 15(Suppl. 6):2001;18-21.
38. Schweppe K.W. Currrent place of progestins in the treatment of endometriose-related complaints. Gynec. Endocrinol. 15(Suppl. 6):2001;22-28.
39. Schindler A.E. Progestins and endometrial cancer. Gynec. Endocrinol. 15(Suppl. 6):2001;29-36.
40. Winkler U.H., Schindler A.E., Brinkmann U.S., Ebert C., Oberhoff C. Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynec. Endocrinol. 15(Suppl. 6):2001;37-43.
41. Pasqualini J.R., Ebert C., Chetrite G.S. Biological effects in breast cancer. Gynec. Endocrinol. 15(Suppl. 6):2001;44-52.
42. Campagnoli C., Abba C., Ambroggio S., Biglia N., Ponzone R. Breast cancer and hormone replacement therapy: putting the risk into perspective. Gynec. Endocrinol. 15(Suppl. 6):2001;53-60.
43. Van de Ven J., Sprong M., Donker G.H., Thijssen J.H.H., Mak-kregar S., Blankenstein M.A. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogues. Gynec. Endocrinol. 15(Suppl. 6):2001;61-68.
44. Druckmann R. Female sex hormones, autoimmune diseases and immune response. Gynec. Endocrinol. 15(Suppl. 6):2001;69-76.